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Introduction
Outbreaks caused by multidrug resistant Acineto­
bacter baumannii strains have been intensively doc-
umented worldwide (Zarrilli et al. 2013). With the 
increasing number of carbapenem-resistant A. bau­ 
mannii, outbreaks of A. baumannii were expand-
ing. One data showed that resistance to carbapenem 
increased from 1.0% in 2003 to 58.0% in 2008 in Detroit 
Medical Center health system (Reddy et al. 2010). In 
China, A. baumannii has recently become an impor-
tant pathogen causing the nosocomial infection in hos-
pitals. The infection rate of A. baumannii is always in 
the top three in total clinical isolates of Gram-negative 
bacilli, second only to Escherichia coli and Klebsiella 
pneumoniae. In 2014, A. baumannii isolated from non-
fermenting Gram-negative bacilli was always in the 
first place in clinical tests (Wang et al. 2013; Hu et al. 
2014; Hu et al. 2015).
The analysis results of multilocus sequence typing 
(MLST) demonstrated that multiple STs were prevalent 
in the outbreak regions. Ying reported that ST208 was 
the most prevalent, followed by ST191 and ST729 in the 
398 isolates collected in seven regions of South China 
in 2012 (Ying et al. 2015). Through the whole genome 
sequencing, it was found that blaOXA-23-producing 
A. baumannii ST208 strains emerged and rapidly spread 
in Hangzhou First People’s Hospital (Chen et al. 2018). 
Just recently, Jeon et al. (2018) reported that sequence 
type (ST) 191 was the predominant clone, followed by 
the ST208 and ST369 in the hospital in Korea.
At present, A. baumannii strains were mainly iso-
lated from the clinical specimens, as blood, urine, 
tissues, and sputum (Bogaerts et al. 2006; Zong et al. 
2008; Mendes et al. 2009; Yang et al. 2010; Chen et al. 
2013). In our laboratory, we have been focused on the 
epidemiology of A. baumannii isolates from sputum 
(Jiang et al. 2013; Jiang et al. 2014). However, some 
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A b s t r a c t
To understand the molecular epidemiology and antibiotic resistance of air and clinical isolates of Acinetobacter baumannii, the intensive 
care unit settings of a hospital in Northern China were surveyed in 2014. Twenty non-duplicate A. baumannii isolates were obtained from 
patients and five isolates of airborne A. baumannii were obtained from the wards’ corridors. Pulsed field gel electrophoresis (PFGE) and 
multilocus sequence typing (MLST) were used to analyze the homology relationships of isolates. Resistance and resistance genes were 
detected by drug susceptibility test and PCR. The results demonstrated that all isolates can be classified into eight PFGE types and four 
sequence types (ST208, ST195, ST369 and ST530). A pair of isolates from patients (TAaba004) and from the air (TAaba012) that share 
100% similarity in PFGE was identified, indicating that air might be a potential and important transmission route for A. baumannii. 
More than 80% of the isolates were resistant to carbapenems and aminoglycoside antibiotics. Twenty-four isolates, which were resistant 
to carbapenems, carried the blaOXA-23-like gene. The data indicated that air might be an alternative way for the transmission of A. baumannii. 
Hospitals should pay more attention to this route, and design new measures accordingly.
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reports have shown that A. baumannii can survive 
and transmit in the air (Allen et al. 1987; Obbard et al. 
2003). To date, the homology relationship between the 
airborne A. baumannii isolates from hospital air and 
those isolated from patients has not been extensively 
studied. In this study, twenty-five isolates of non-dupli-
cate A. baumannii were obtained from patients and 
the air of wards’ corridors during May – Jun. and Oct. 
– Nov. of 2014. The molecular epidemiological char-
acterization of the isolated A. baumannii, such as drug 
resistance, and types of resistance genes, was compared 
to understand the relationship between the airborne 
A. baumannii and those isolated from patients.
Experimental
Materials and Methods
Ethical approval. Samples of patients were acquired 
during a routine checkup by medical staffs. The study 
was approved by the Ethics Committee of Tai’an City 
Central Hospital and carried out in accordance with the 
approved guidelines.
Source of the isolates. From May 12 to Jun. 5 and 
Oct. 11 to Nov. 15, 2014, A. baumannii isolates were 
obtained from patients hospitalized in four different 
wards, including the intensive care unit (ICU), emer-
gency intensive care unit (EICU), respiratory intensive 
care unit (RICU) and geriatrics ward (GW). Mean-
while, airborne A. baumannii isolates were obtained 
from the air of the wards and adjacent corridors using 
the Andersen 6-stage air sampler. Each stage of the 
sampler has a plate with 400 holes of uniform diameter, 
according to the method described in previous studies 
(Andersen et al. 1958; Obbard et al. 2003). In brief, the 
sampler was placed in the center of wards and corri-
dors (closed) at a height of 1.5 m above the ground. 
Airborne A. baumannii was collected at a calibrated 
flow rate of 28.3 l/min for 20 min, and MacConkey 
agar (Oxoid, Basing stoke, England) was used as the 
sampling medium. At each sampling site, four duplicate 
air samples were collected once per week. The number 
of colonies was about 30–300 in each stage. Tempera-
ture and relative humidity were recorded throughout 
the sampling periods (temperature 20–25°C; relative 
humidity 73–83%). 
Bacterial identification and drug susceptibility 
test. Bacterial identification was performed by using 
an VITEK-2 bacterial instrument (BioMerieux, Lyons, 
France) following the operation instruction. Drug sus-
ceptibility test was performed by two different meth-
ods: the sensitivity of tigecycline and polymyxin B was 
detected by the Etest method (AB Biodisk, Solna, Swe-
den); the sensitivity of the remaining fourteen antibiotics 
was detected using the minimal inhibitory concentration 
method. The susceptibility testing result of tigecycline 
was explained according to Food and Drug Admin-
istration (FDA) guideline (http://www.fda.org.uk/ 
sitemap.aspx). The criteria of the susceptibility of other 
agents were adapted from the Clinical and Laboratory 
Standards Institute (CLSI) (http://clsi.org/standards/). 
The criteria of multidrug resistant (MDR) A. bau­ 
mannii, extensively drug-resistant (XDR) A. baumannii 
and pandrug-resistant (PDR) A. bau mannii were refer-
red to the previously described (Magiorakos et al. 2012).
Pulsed field gel electrophoresis (PFGE). Clonal 
relatedness of 25 A. baumannii strains isolated in this 
study was determined by PFGE (Ribot et al. 2006). 
Briefly, the bacterial chromosomal DNA was digested 
with 60 U of ApaI (Takara, Dalian, China) in a 37°C. 
Salmonella serotype Braenderup strain (H9812) was 
digested with XbaI (Takara, Dalian, China) and used 
as the molecular weight standard, the DNA fragments 
were separated on agarose gel using a clamped homo-
geneous electric field electrophoresis-Mapper XA sys-
tem (Bio-Rad, California, USA). The PFGE images were 
analyzed using the Gel Doc software (Bio-Rad, Cali-
fornia, USA) and the genetic relatedness of the A. bau­ 
mannii isolates were evaluated using the BioNumerics 
software (Applied Maths, Sint-Martens-Latem, Bel-
gium). The cutoff level of 85% was set to define clonal 
clustering of the PFGE types.
Multilocus sequence typing (MLST). The sequence 
types (STs) of A. baumannii strains were determined by 
MLST using the previously described method (Bartual 
Amikacin 3 15.0% 17  85.0%
Ceftazidime 0 0.0% 20 100%
Ciprofloxacin 0 0.0% 20 100%
Levofloxacin 0 0.0% 20 100%
Gentamicin 0 0.0% 20 100%
Tobramycin 3 15.0% 17  85.0%
Ceftriaxone 0 0.0% 20 100%
Cefotaxime 0 0.0% 20 100%
Cefepime 0 0.0% 20 100%
Imipenem 0 0.0% 20 100%
Meropenem 0 0.0% 20 100%
Trimethoprim/
sulfamethoxazole
 6 30.0% 14 100%
Piperacillin/
tazobactam 
0 0.0% 20 100%
Tigecycline 20 100% 0 0.0%
Polymyxin B 20 100% 0 0.0%
Table I
Susceptibility profiles of 20 clinical A. baumannii isolates.
Antibiotics
Susceptible Resistant
Number Rate (%)Rate (%)Number
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et al. 2005). In brief, the internal fragments of seven 
housekeeping genes, including citrate synthase (gltA), 
DNA gyrase subunit B (gyrB), glucose dehydrogenase 
B  (gdhB), homologous recombination factor (recA), 
60-kDa chaperonin (cpn60), glucose-6-phosphate 
isomerase (gpi) and RNA polymerase σ70 factor (rpoD) 
were amplified by PCR. The positive sequences were 
further analyzed using the A. baumannii PubMLST 
database (http://pubmlst.org/abaumannii).
Drug resistance genes. Bacterial DNA were extra c-
ted and the carbapenemase genes, including blaOXA-23-like, 
blaOXA-24-like, blaOXA-48, blaOXA-50, blaOXA-51-like, blaOXA-55, 
blaOXA-58-like, blaOXA-60, and blaOXA-64, the 16S rRNA methy-
lase genes armA and rmtB were amplified by PCR as 
previously described (Shen et al. 2008; Yang et al. 2011). 
The positive bands were sequenced and then compared 
to the Genbank database (Jiang et al. 2014).
Results
Isolation of A. baumannii strains. Twenty 
A. baumannii clinical strains were isolated from 
356 patients and five strains were isolated from 4 out 
of 64 air samples in duplicate during this experimental 
period (8  weeks). Wherein two A. baumannii strains 
(TAaba015 and TAaba014) were isolated from the same 
air sample from ICU corridor in 08.11.2014.
Drug susceptibility patterns. A total of twenty-five 
non-duplicate A. baumannii isolates were obtained, 
including twenty from the clinical samples and five 
from the adjacent corridors of the wards. Fifteen com-
monly used antibiotics (amikacin, ceftazidime, cipro-
floxacin, levofloxacin, gentamicin, tobramycin, ceftri-
axone, cefotaxime, cefepime, imipenem, meropenem, 
trimethoprim/sulfamethoxazole, piperacillin/tazobac-
tam, tigecycline, and polymyxin B) were selected for 
drug susceptibility test. The result showed that only 
one out of the five airborne isolates (TAaba013) was 
non-MDR A. baumannii, which was only resistant to 
ceftazidime, ceftriaxone, cefotaxime, and cefepime. All 
twenty clinical isolates were MDR A. baumannii, and 
susceptible to tigecycline and polymyxin B.
Drug resistance genes. All isolates had the 
blaOXA-51-like resistant gene, and twenty-four had the 
blaOXA-23-like gene except one airborne isolate (TAaba014). 
However, other seven resistance genes of carbapen-
emases were not detected in this study. These results 
indicated that blaOXA-23-like gene was responsible for the 
carbapenemase resistance. In addition, twenty isolates 
carried the 16S rRNA methylase gene armA. No rmtB 
gene was detected in all isolates.
PFGE and MLST. As shown in Fig. 1, the isolates 
can be clustered into eight PFGE types (A-H) and four 
STs (ST208, ST369, ST195 and ST530). One airborne 
isolate (TAaba012) had the same PFGE and ST types 
as one clinical isolates (TAaba004). They were isolated 
from the same ward (EICU) during the same period 
(May – Jun 2014). Similarly, in another ward (inten-
sive care unit, ICU), one airborne isolate (TAaba008) 
was found to be closely related to three clinical iso-
lates (TAaba002, TAaba009, and TAaba011) in terms 
of PFGE and ST types (type D and ST208, respectively).
In the second sampling period (Oct. 11 to Nov. 15, 
2014), we collected three non-reduplicate airborne iso-
lates (TAaba013, TAaba014 and TAaba015). We did not 
find any clinical isolates with the same PFGE and ST 
types. In particular, the PFGE and ST types of TAaba013 
were different from any isolates obtained in this study.
Discussion
A. baumannii is a predominant cause of nosocomial 
infections, and the organism has been detected in water, 
soil, and on the surface of human body. A recent study 
has shown that some A. baumannii environmental iso-
lates are able to survive in tap, normal saline, and dis-
tilled water with a wide range of pH and temperature 
for a long period of time (Obeidat et al. 2014). It makes 
it harder for the prevention of A. baumannii spread in 
a nosocomial environment. A. baumannii is often trans-
mitted through physical objects, like stethoscopes, com-
puters, milk pumps, and headboards of beds. In this 
study, we investigated the genetic relationship of the 
A. baumannii isolates from the air and patients, and the 
possible transmission pathway through the air.
Amikacin R R
Ceftazidime R R
Ciprofloxacin R R
Levofloxacin R R
Gentamicin R R
Tobramycin R R
Ceftriaxone R R
cefotaxime R R
Cefepime R R
Imipenem R R
Meropenem R R
Trimethoprim/sulfamethoxazole R R
Piperacillin/tazobactam R R
Tigecycline S S
Polymyxin B S S
Table II
Susceptibility profiles of the airborne and clinical strains
with the highest similarity.
Note: “R” indicates resistant, “S” indicates susceptible.
Strain / Antibiotics TAaba004 TAaba012
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Our results show that one airborne A. baumannii 
(TAaba012) isolated in the EICU and one clinical iso-
late (TAaba004) isolated in the same ward shares 100% 
similarity in PFGE and MLST, indicating A. bauman­
nii might be transmitted through air. Another airborne 
isolate (TAaba008) obtained in ICU was also found to 
be the same strain as three clinical isolates (TAaba002, 
TAaba009, and TAaba011). Based on the genetic rela-
tionship of the airborne and clinical isolates, we specu-
late that there could exist an air-mediated spread of this 
A. baumannii strain. Moreover, many studies demon-
strated that airborne A. baumannii could be detected 
in ICU and airborne transmission of A. baumannii was 
possible (Munoz-Price et al. 2013; Spellberg et al. 2013; 
Yakupogullari et al. 2016).
A total of twenty clinical isolates were obtained 
during the sampling period of this study, but only 
one isolate was found in the air, indicating airborne 
transmission might be affected by many factors, such 
as length of hospital stay, humidity, temperature, etc. 
Since our dataset are relatively small, we cannot draw 
any exclusive conclusion. Moreover, because horizontal 
gene transfer that can jeopardize clonal strains, PFGE 
is no longer the most effective technique for A. bau­
mannii typing (Salipante et al. 2015), and our data can 
only confirm that the same strain was isolated from 
air and the specimens from patients, which could sug-
gest an alternative route of transmission through air. 
More systematic studies with a longer period of sam-
pling should be constructed to better understand the 
airborne pathway. 
Treatment of A. baumannii infections is particularly 
difficult because of the resistance to a broad range of 
antibiotics, especially with the increasing of resistant to 
carbapenems (Lee et al. 2012). Although mechanisms 
of resistance to carbapenems were very complex, resist-
ance genes play an important role in this process. It has 
been reported that blaOXA-23-like-producing A. baumannii 
were found worldwide (Le et al. 2008; Runnegar et al. 
2010; Mosqueda et al. 2013). In this study, the analy-
sis showed that all strains had blaOXA-51-like gene, one 
intrinsic gene in A. baumannii. Moreover, 96% strains 
(24/25) carried the blaOXA-23-like gene, except TAaba014. 
These results indicated that both genes were mainly 
responsible for the carbapenems resistance in this 
area, especially the blaOXA-23like gene and it was gener-
ally believed that blaOXA-23-like gene was responsible for 
carbapenem resistance in China (Ruan et al. 2010; Liu 
et al. 2015). Additionally, it has been reported that 16S 
rRNA methylase gene armA was closely related to the 
aminoglycosides resistance (Yokoyama et al. 2003), and 
80% (20/25) strains had the 16S rRNA methylase gene 
armA. All of the strains showed the resistance to amika-
cin, tobramycin and gentamicin. Antibiotic resistance 
is a serious global public problem.
Taken together, in this study, we isolated twenty 
clinical A. baumannii from patients and five airborne 
A. baumannii from the ward environment. Out of the 
five airborne A. baumannii, one was found to have the 
same PFGE and ST type with one strain isolated from 
patients, indicating that the air may be an important 
and potential transmission way for A. baumannii. 
Considering the seriousness of nosocomial infections 
of A. baumannii, prophylactic strategies in controlling 
the air transmission of A. baumannii should be consid-
ered when new measures are designed for controlling 
nosocomial infections.
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